This study is accepting new patients by invitation only
A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
a study on Achondroplasia
Summary
- Eligibility
- for people ages 5–17 (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study started
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Sponsor
- BioMarin Pharmaceutical
- Links
- NIH Genetics Home Reference related topics: Achondroplasia
- NIH Genetic and Rare Diseases Information Center resources: Achondroplasia
- ID
- NCT03197766
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated
- March 26, 2018